3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
Rituximab
99
Cyclophosphamide
63
fludarabine phosphate
55
Peripheral Blood Stem Cell Transplantation
52
Mycophenolic Acid
34
Whole-Body Irradiation
33
Bortezomib
33
ibrutinib
29
Dexamethasone
27
Tacrolimus
26
Cyclosporine
25
Busulfan
23
Etoposide
22
Melphalan
20
Filgrastim
20
zanubrutinib
18
Methotrexate
18
Lenalidomide
18
Antilymphocyte Serum
18
Radiotherapy
16
Bendamustine Hydrochloride
14
Sirolimus
13
Calcium Dobesilate
11
Flow Cytometry
10
Everolimus
10
venetoclax
9
ibritumomab tiuxetan
9
Prednisone
9
Indium
9
Cyclosporins
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Immunotherapy
×
Lymphoid
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled